Article
Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk.
Journal of thrombosis and haemostasis : JTH - 1 Aug 2024
Hasser Emily K, Brody Jennifer A, Bartz Traci M, Thibord Florian, Li-Gao Ruifang, Kauko Anni, Wiggins Kerri L, Teder-Laving Maris, Kim Jihye, Munsch Gaëlle, Haile Helen G, Deleuze Jean-Francois, van Hylckama Vlieg Astrid, Wolberg Alisa S, Boland Anne, Morange Pierre-Emmanuel, Kraft Peter, Lowenstein Charles J, Emmerich Joseph, Sitlani Colleen M, Suchon Pierre, Rosendaal Frits R, Niiranen Teemu, Kabrhel Christopher, Trégouët David-Alexandre, Smith Nicholas L
Abstract excerpt
BACKGROUND: Increased risk of venous thromboembolism (VTE) is a life-threatening side effect for users of oral contraceptives (OCs) or hormone therapy (HT). OBJECTIVES: To investigate the potential for genetic predisposition to VTE in OC or HT users, we conducted a gene-by-environment case-only meta-analysis of genome-wide association studies (GWAS). METHODS: Use or nonuse of OCs (7 studies) or HT (8 studies) at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
